Bagsværd, Denmark, 1 Nov 2024:  Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to ad......
View Details

Related News

• Dehradun police busted drug manufacturing Unit operated under the guise of 'Green Herbal Factory' in Sahaspur area (06-12-2024)

---

• Ballari maternal deaths: Ready to resign if I'm at fault, says Karnataka HM (06-12-2024)

---

• FDA Approves New Drug for Lung and Pancreatic Cancers (06-12-2024)

---

• Surat police nab 13 bogus doctors in fake degree scam (06-12-2024)

---

• Maternal death toll in Ballari hospital touches five after one more woman dies (06-12-2024)

---

• Two sacks of medicines recovered from a government flat in Saharanpur (06-12-2024)

---

• Action taken against 116 Pharma companies in Himachal found not meeting standards (05-12-2024)

---

• Govt allocates Rs 4534.28 Crores for promotion of AYUSH (05-12-2024)

---

• FDA finalizes AI-enabled medical device life cycle plan guidance (05-12-2024)

---

• Tumakuru police seize 1,700 tapentadol tablets sold over the counter (05-12-2024)

---